Meniere's disease in that it occurs in pre-existing ear pathology in patients who have a profound unilateral or total deafness that was caused by infection, trauma, or unknown causes during childhood or adulthood. We performed a retrospective review of 160 patients with ipsilateral, contralateral, or bilateral DEB. Eighty-seven patients who did not respond to medical therapy underwent surgical treatment. Our findings indicate that the more conservative surgical procedures-endolymphatic sac surgery, cochleosacculotomy, and streptomycin perfusion-are all as effective as and less destructive than labyrinthectomy for controlling vertigo. The clinical results ofthis study would seem to support the observations of others that DEH and Meniere's disease are related disorders caused predominantly by cases of viral labyrinthitis with unknown etiology.
Introduction
Delayed endolymphatic hydrops (DEH) was first reported in 1975 in papers by both Nadol et all and Wolfson and Leiberman.' The condition was named and further elaborated on by Schuknecht, who classified DEH as either ipsilateral, contralateral, or bilateral. 3 Ipsilateral DEH is characterized by the early onset of a profound or total hearing loss in one ear in conjunction with Meniere' stype vertigo. Ipsilateral DEH is often accompanied by nausea and vomiting. It is occasionally associated with tinnitus, pressure, or fullness in the same ear after a period of years has elapsed. In the contralateral expression, the patient experiences a fluctuating and progressive hearing loss-with or without Meniere' s-type episodic vertigoin the ear opposite the one that earlier experienced the hearing loss. Patients with bilateral DEH experience hearing loss in both ears some years before the onset of symptomatic endolymphatic hydrops.
The most common causes of DEH are inflammation, trauma, and unknown events during childhood. Schuknecht et al made a histopathologic analysis of the temporal bones of two patients with contralateral DEH.4 They reported that the pathologic changes in the deaf ears were consistent with viral labyrinthitis, whereas the changes in the hearing ears were similar to those seen in Meniere's disease.
The first-line treatment is medical therapy. If DEH proves to be refractory to this, surgery is indicated. The type of surgical procedure depends on whether the patient has ipsilateral or contralateral DEH. For patients with ipsilateral DEH, labyrinthectomy has proved to be curative. For contralateral DEH, Schuknecht reported in 1978 that there was no satisfactory surgical treatment? Since then, however, Hicks and Wright reported that endolymphatic sac (ELS) surgery in patients with contralateral hydrops is relatively safe, provides an excellent chance of eliminating or controlling vertigo and maintaining or improving hearing, and carries a low risk of surgical anacusis.' They consider ELS surgery to be the only option when symptoms of contralateral DEH are debilitating and refractory to medical treatment.
In this article, we describe our retrospective review of 160 patients with DEH. We discuss the clinical implications of medical treatment and evaluate the surgical options for those patients whose symptoms do not respond to medical therapy. We introduce alternate surgical modalities for ipsilateral DEH, and we emphasize the need for caution in the surgical treatment of contralateral and bilateral DEH.
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tralateral, and one was bilateral. Just less than half of these patients responded to conservative treatment with a combination of a vasodilator, labyrinthine sedative, diuretic, low-salt diet, and psychological support. In 87 patients (54%), symptoms were refractory to medical therapy, and they required surgical treatment. (In another case that is not included in this series, a patient whose symptoms mimicked delayed hydrops was found during surgery to have an intravestibular lipoma.")
As is the procedure for assessing other patients with dizziness and vertigo, the evaluation of these 160 patients included (1) a careful history, (2) an otolaryngologic examination, (3) a blood workup, (4) an audiometric profile, (5) electronystagmography (ENG) with caloric testing, (6) radiologic studies, and (7) a dehydration test if necessary.
ENG with caloric testing showed that cochlear function was generally not parallel to vestibular function, particularly in the contralateral cases. Not all of the deafened ears showed a reduced vestibular response, and the betterhearing ears did not always show a normal vestibular response.
Ipsilateral and bilateralDEH. Among the 105 patients with ipsilateral DEH, the presumed causes of hearing loss were otitis media and mastoiditis in 21 cases, sudden deafness in 12, mumps and viral labyrinthitis in 10, head injury in 10, high fever in three, acoustic trauma in three, drug intoxication in two, and anaphylactic shock in one case (table 1) . There were also 35 cases caused by an unknown etiology during childhood and eight cases of unknown cause during adulthood. At their initial visit, these patients' ages ranged from 16 to 72 years (mean: 41). Their ages at the onset of hearing loss ranged from 2 to 50 years (mean: 15) , and their ages at the onset of vertigo ranged from 9 to 71 years (mean: 33) . The length of the delay between the onset of deafness and the onset of vertigo ranged from 2 to 53 years (mean: 22) . All patients with ipsilateral DEH had normal or satisfactory hearing in the opposite ear.
Surgery was necessary for 67 patients, including the one with bilateral DEH. An initial transmastoid labyrinthectomy was performed on 56 patients,ELS surgery on six, and cochleosacculotomy on five. Three patients who had failed initial ELS surgery later underwent a labyrinthectomy.
Contralateral DEH. In the 54 patients with contralateral DEH, the presumed causes of hearing loss were upper respiratory tract infection with high fever in seven, otitis media and mastoiditis in five, mumps in five, head injury in five, sudden deafness in four, measles in two, acoustic trauma (by firecrackers) in one, and meningitis in one (table 2) . There were 18 unknown causes that occurred during childhood and six during adulthood. At the initial There have been reports ofliver failure and death Inpatients with cancer receiving concurrent medications Including potentlall he atotoxlc cytotoxic chemotherapy and antibiotics. The etlolog ofthe liver failure Isunclear.
Integum,ntary: .
Redletlon-Induced Naueea and Vomillng: The adverse events reported inp8tients receiving ZOFRAN Tablets and concurrent radiotherapy were similar tothose reported inpatients receiving ZOFRAN Tablets and concurrent chemotherapy. The most frequently rep_orted adverse events were headache, constipation, and diarrhea. Postoperative Nausea and Vomiting: The following adverse events have been reported In~5% ofadutt patients receiving muttlple concomitant perlop'eratlve and postoperative medications. Wnh the exception of headache, rates of these events were notsignificantly different Inthe ondansetron and placebo groups. Individual doses aslarge as150mgand total daily doses aslarge as252mg have been inadvertently administered intravenously wnhout significant adverse events. These doses are more t h~~1~Jloe; t~~:~~e~s~n~~~n' i : i l r st~s: bove, thefollowing events have been described in theselling of ondansetron overdose: "Sudden blindness" (amaurosis) of 2 to 3 minutes duration plus severe constipation occurred in one patient thatwas administered 72mgof ondansetron Intravenously asa single dose. Hypotension (and faintness) occurred in a patient thattook 48mgof ZOFRAN Tablets. Following infusion of 32mgover onlya 4-minute period, avasovagal episode withtransient second degree heart block was observed. Inallinstances, theevents resolved compietely.
GlaxoWellcome
The following adverse events have been reported In~5% ofadult patients receiving concurrent moderately emetogenlc chemotherapy, primarily cyclophosphamide-based regimens. 
BRIEF SUMMARY
CardloVllCulaf: Arrhythmias (Including ventricular and supraventricular tachycardia, premeture ventricular contractions, and atrial florlllatlon), bradycardia, electrocartllographlc alterations (Including second degree heart block, and ST segment depression), palpitations, and syncope. G,ne"l: Flushing. Rare cases ofhypersensnivlty reactions, sometimes severe (e.g., anaphylaxis/ anaphylectold reactions, angioedema, bronchospasm, cardiopulmonary arrest, hypotension, laryngeal edema, iaryngospasm, shock, shortness ofbreath stridor) have also been reported.
HapalDblll.ry: LIVer enzyme abnormalities have been reported. Liver faliure and death have been reported In a :~:n~~!~~:~~. sl ncI Udi ng potentially hepatotoxic cytotOXic chemotherapy and and bumlng atsnB ofInjection. LowerRaap/"lDry: Hiccups =:::' ' J'~~~~Oculogyric crisis, appearing alone, aswell aswnh other dystonic reactions.
SpaDI.1 Sa/ll8l: Transient blurred vision, Insome cases assocleted with abnormalities ofaccommodation, and transient dizziness during orshortly after I.V. Infusion. ZD=t =: r: JhA~~~~: r~~: ur: i~~Ĩ~~~f l~~a:~~n~~~1ra~h~v~~~e:~~a~~; Ĩ~; , a~~~~s~f emot her epy' -I nduced Nausea and Vomiting: The f O~OWl ng a~ver se events have been reported In?;5% ofadutt patients receiving concurrent highly emetogenlc clsplatln-based chemotherapy regimens (clsplatln dose~50 mgim'). visit, patients' ages ranged from 20 to 65 years (mean: 46). Their ages at the onset of hearing loss ranged from 4 to 50 years (mean: 14) , and their ages at the onset of inner ear symptoms ranged from 15 to 75 years (mean: 41). The length of delay between the onset of deafness and the onset of vertigo ranged from 5 to 66 years (mean: 28). Surgery was required for 16 of these patients. All of them had a fluctuating hearing loss in addition to their vertigo, as evidenced by a positive glycerol test as documented by serial audiography.
Results
Ipsilateral and bilateral DEH. Among the 56 patients who underwent an initial or revision transmastoid labyrinthectomy, symptoms were completely controlled in 49 (88%), including the three of the six (seven ears) who had failed ELS surgery (see case report 1) (table 3) . The other seven patients experienced a relief of vertigo but not dizziness; their dizziness was brought under control with medical therapy. The patient with bilateral DEH continued to experience dizziness, which was controlled by medication (see case report 2).
A complete relief of symptoms was achieved in four of the five patients who underwent a cochleosacculotomy. The remaining patient was subsequently and successfully treated with vestibular streptomycin perfusion (see case report 3).
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Including the bilateral case, a total of 68 surgical procedures were performed for ipsilateral DEH.
Contralateral DEH. All 16 patients with contralateral DEH whose vertigo was refractory to medical therapy underwent ELS surgery with various draining methods. In the seven most recent cases, the endolymphatic sac was drained and its lumen expanded by insertion of a fanfolded Silastic sheet (endolymphatic sac balloon surgery). In four patients, a device with a capillary tube (Arenberg's inner ear valve or Austin's endolymph dispersement drain) was inserted into the endolymphatic duct. Four other patients had their endolymphatic sac drained by a simple incision, and one patient underwent decompression alone.
Thirteen of the 16 patients (81%) experienced a complete resolution of vertigo following ELS surgery, while the remaining three experienced substantial control; these latter three patients reported dizziness, which was controlled medically (table 4) . Hearing levels were maintained in 14 patients, improved in one (see case report 4), and worse in one (see case report 5).
Case reports
Five selected case reports follow, describing two patients with ipsilateral DEH, the one with bilateral DEH, and two with contralateral DEH.
Case 1 (ipsilateral Case 3 (ipsilateral) . In 1987, a 26-year-old woman had suddenly experienced a nearly total deafness on the left side, which was accompanied by tinnitus and fullness in the same ear. Left ear audiometry revealed only residual responses at 1 and 2 kHz. No improvement was noted after medical treatment.
Two years later, the patient complained of episodic vertigo, nausea, and vomiting. ENG showed a normal vestibular function bilaterally. Audiography confirmed the total deafness on the left (10 dB PTA), a speech reception threshold of 10 dB, and a 100% SDS on the right side.
When 4 months of medical treatment proved to be ineffective, a cochleosacculotomy was performed on the left ear. The patient reported no further vertigo attacks postoperatively, but she did complain of dizziness and disabling disequilibrium. Streptomycin perfusion (0.1 ml of 25 ug/ml streptomycin compound) of the labyrinth was initiated 7 months later. Postoperatively, the patient's fistula test was negative, and she exhibited no response to the maximal (icewater) caloric test. The patient continues to be asymptomatic. .
Case 4 (contralateral). In 1983, a 40-year-old woman severe sensorineural hearing loss in the left ear that began during her childhood following an episode of otitis media and mastoiditis. During the previous year, she had experienced episodic vertigo and tinnitus in the left ear. Her physical examination revealed an atrophic scarring of the left tympanic membrane. Audiography showed residual responses at 0.25 and 0.5 kHz in the left ear and normal hearing in the right. ENG revealed a canal paresis in the left ear and a normal response on the right. Blood test results were unremarkable, but a mastoid x-ray showed sclerosis on the left. In 1979, ELS surgery was performed on the left ear, but it failed to control her vertigo. Three months later, when her vertigo had become incapacitating, a labyrinthectomy was reluctantly performed to relieve her symptoms.
Case 2 (bilateral). A 29-year-old woman had had a profound sensorineural hearing loss in both ears since the age of 4 years following an episode of high fever. During the previous year, she began to experience episodic vertigo and tinnitus and fullness in both ears.
A physical examination revealed that her eardrums were normal. Audiography confirmed a profound bilateral sensorineural hearing loss of 85 dB pure-tone average (PTA) in both ears, a 12% speech discrimination score (SDS) in the right ear, and an 8% SDS in the left. ENG revealed a reduced vestibular response in both ears. Blood test results were unremarkable, and dehydration testing was negative bilaterally. Radiologic study of the mastoids was also unremarkable.
Because the woman's vertigo was disabling, ELS surgery was performed on the right ear with an Austin endolymph dispersement drain in 1987. One month later, the same procedure was employed on the left ear. Afterward, the woman reported no recurrence of her vertigo attacks. She did occasionally experience adjunctive spells, which were controlled medically. She has aidable hearing.
Vertigo
Complete control Substantial control came to our institution with a profound sensorineural hearing loss in the left ear, which she had had since the age of 10 years following an attack of bacterial meningitis. The patient said that she was now experiencing a fluctuating hearing loss in the right ear, which was accompanied by tinnitus. The results of her otolaryngologic and physical examinations were unremarkable. Audiography revealed a profound sensorineural hearing loss in the left ear of 90 dB PTA and a low-frequency hearing loss in the right ear of 40 dB PTA with a 4-kHz dip. Tone-decay tests were negative on both sides. ENG with caloric testing produced a reduced vestibular response in the left ear and a normal response in the right. Computed tomography (CT) revealed hydrocephalus. The patient's glycerol test was positive in the right ear. The woman was diagnosed as having contralateral DEH associated with hydrocephalus, and medical treatment was prescribed. Two years later, she returned complaining of serious disequilibrium, a transient floating sensation, and noise intolerance in the right ear. ENG again revealed a normal response in the right ear. Repeat audiography showed 95 dB PTA and a 0% SDS in the left ear and 40 dB PTA and 36% SDS in the right. High-resolution CT and pneumocisternography were both negative, indicating that there were no tumors in the cerebellopontine angle and internal auditory canals. A repeat glycerol test was again positive on the right. The patient's symptoms were controlled by medical therapy.
Five years later in 1990, the patient began to experience severe vertigo, nausea, and vomiting. Her hearing had deteriorated in the right ear and her disequilibrium had intensified. Her Romberg's test was positive. All other test results were similar to those previously conducted. The woman's disequilibrium and headaches had become so severe (which indicated recurrent hydrocephalus) that a ventriculoperitoneal shunt was reluctantly inserted. The shunt was successful in relieving her symptoms. One week after surgery, her vertigo gradually diminished and her hearing threshold in the right ear had improved from 55 to 40 dB PTA. One month postoperatively, the patient was discharged from the hospital.
Three days after discharge, the patient returned to the emergency room complaining of hemiparesis and severe headache on the right. CT revealed the presence of a subdural hemorrhage. A craniotomy was performed and a ventriculoperitoneal shunt revision was successfully performed. The patient recovered, and conservative measures eventually stabilized the cochleovestibular symptoms. To date, she remains asymptomatic.
Cases of concomitant DEH and hydrocephalus are undoubtedly caused by meningitis. However, the relationship between the symptoms of DEH and hydrocephalus has not yet been satisfactorily explained.
Case 5 (contralateral). A 42-year-old woman had been completely deaf in her left ear since the age of 8 years. The 84 cause of her deafness was unknown. During the previous year, she began experiencing episodic vertigo, tinnitus, and fullness in her right ear.
Her tympanic membranes were normal, and the rest of her physical examination was unremarkable. A preoperative audiogram showed 25 dB PTA and a 100% SDS in the right ear and confirmed her total deafness in the left. Her blood test results were unremarkable, and her mastoid xray was normal on both sides. A glycerol test was positive on the right side. Because her vertigo had become incapacitating, ELS surgery was performed on the right ear with an Arenberg's inner ear valve in 1984. Following surgery, the patient's hearing increased by 10 dB PTA, and to date her vertigo is still completely resolved.
Discussion
Symptomatology. Schuknecht and Gulya described endolymphatic hydrops in terms of its symptomatic and asymptomatic forms.' DEH can be considered an asymptomatic, clinically silent type because a unilateral deafness caused by an earlier otologic insult can exist for years before it becomes symptomatic. Meanwhile, Meniere's disease is defined as the idiopathic, symptomatic form of endolymphatic hydrops of unknown cause because symptoms develop in one or both ears that had previously had normal auditory and vestibular functions. This acquired form of endolymphatic hydrops or Meniere's syndrome includes cases in which a documented insult has been caused by either inflammation or trauma to a previously normal labyrinth.
Ipsilateral DEH is characterized by symptoms that mimic those of Meniere's-type vertigo. These symptoms occur after a lapse of several to many years following the onset of deafness in that ear.1.2 Symptoms of contralateral DEH, in which a Meniere's symptom complex develops in the ear opposite the deaf ear, typically include progressive and fluctuating hearing loss, aural pressure and tinnitus, and/or episodic attacks of vertigo accompanied by nausea and vomiting. In bilateral DEH, a profound hearing loss in both ears precedes the onset of symptoms.
It has been proposed that DEH is a pathologic condition that is the final common manifestation of a variety of otologic insults, including infection (either viral or bacterial), trauma (either physical or acoustic), the onset of sudden deafness, and other causes known and unknown.' Schuknecht suggested that in DEH, the reabsorption of endolymph is compromised as a result of two possible consequences of the original insult: either damage to the endolymphatic sac or blockage of the vestibular aqueduct.' If so, this implies that some auditory and/or vestibular function remains because some secretory tissue is still present, although many patients eventually develop cochleovestibular symptoms. Schuknecht and Gulya later described two unique temporal bone histopathologic studies in two patients with The recommended dose for childr.n with pharyngitis/tonsillitis is12mg/kg once a day for 5days Inot toexcead 500 mg/d.y}. ZlTHROMAX" farorelsu.p lon.houldb. givan .11.... ' hourbllare Dr 2 hou,"after. m•• 1. ZI1HROMAXo faro..l.u.p ion.houldnotb. tekln withfaod. contralateral DEH. 7 They found that the histopathology in the deafened ear was typical of viral labyrinthitis (based on its similarity to the histopathology of ears deafened by mumps or measles) and that pathologic changes in the opposite ear were similar to those seen in Meniere's disease." Supplementing their findings with those of Koga et a1 9 and Westmore et al, to who suggested that unilateral hearing loss in childhood is often caused by subclinical mumps, Schuknecht et a1 4 proposed that patients with contralateral DEH probably experienced a viral attack in the hearing ear at the same time the opposite ear was deafened. Schuknecht et al also reported that a subclinical viral labyrinthitis during infancy might be a common cause of both contralateral DEH and Meniere's disease." Support for this suggestion is provided by evidence that some bilateral loss of vestibular function occurs in contralateral cases. Moreover, a subclinical attack in the deafened ear in conjunction with the precipitating cause of hearing loss often results in hydrops in the ipsilateral ear. Caloric test results in the 160 patients in this series resulted in similar findings (tables 5 and 6).
Furthermore, in another series of 159 patients who had a total or profound unilateral hearing loss for a period of years, we found that 14 (8.8%) had DEH-seven contralateral, six ipsilateral, and one bilateral. Of the 145 Volume 80, Number 2 patients who had no DEH symptoms and whose cause of unilateral deafness was unknown, 17 were randomly chosen to undergo caloric ENG in both ears, in addition to routine audiometric and radiologic studies. It is interesting that three of these patients exhibited a reduced vestibular response in the normal-hearing ear and one had no response. Conversely, not all of the deafened ears evidenced a compromised vestibular function; there were five normal caloric responses, indicating that there was a simultaneous vestibular insult in both the deafened ear and the hearing ear.
The eventual development of DEH symptoms in asymptomatic ears appears to be inevitable. Indeed, in a study that spanned 14 years, Kamei found that 27 of 89 juveniles (30%) who had a total unilateral deafness eventually developed episodic vertigo; three also complained of fluctuating hearing in the previously normal contralateral ear." In addition, Schuknecht et al reported that 42 of 62 patients with profound unilateral deafness (68%) had experienced deafness of unknown etiology during childhood. ' Our findings appear to be relevant to the propositions expressed by Schuknecht and Gulya that (1) DEH and Meniere's disease are related, (2) that they are caused primarily by a viral labyrinthitis in patients who have deafness of unknown etiology, and (3) that DEH is a HUANG,L1N Surgical treatment. When medical therapy fails in the treatment of ipsilateral DEH, labyrinthectomy is curative of debilitating vertigo. In our series, labyrinthectomy eliminated vertigo in all 56 patients who underwent the procedure (table 3) . Seven of these patients, most of whom were elderly, continued to experience dizziness; thiswould be expected because the central compensation mechanisms in older patients are often compromised. ELS surgery has been recommended by Hicks and Wright' and by PuleC. 12 It is a more conservative option thanlabyrinthectomy for controlling vertigo, although it is notalwaysas successful.P-" In our series, ELS surgery was performed on six patients (seven ears), and vertigo was eliminatedin three patients.
Two other surgical modalities-cochleosacculotomy and streptomycin perfusion of the labyrinth-were used in our series, and they were also effective. Cochleosacculotomy was successful in four of five patients; the onepatientwho failed was subsequently and successfully treatedwith streptomycin perfusion. When streptomycin is deliveredsystemically at the appropriate dosage, it can selectively destroy the vestibular labyrinth while sparing cochlearfunction. 22 Similarly, local aminoglycoside antibiotics applied adjacent to the inner ear can also selec-88 tively destroy the vestibular stereocilia and sensory cells while leaving the first-order neurons intact and causing only minimal damage to the cochlea.P:"
The slow injection of 0.1 ml of artificial perilymph, containing 25 ug/ml of streptomycin, into the perilymphatic space of the lateral semicircular canal is called Shea's technique." This procedure is performed with a 30-gauge needle in an attempt to destroy the vestibular receptors." In theory, the perilymphatic trabecular meshwork and the membrana limitans should prevent, or at least minimize, the spread of streptomycin into the cochlea, thus preventing adverse effects to cochlear function. Since 1986, Shea has performed 166 streptomycin perfusions, and vertigo was controlled in all cases."
In our series, the three patients who received streptomycin perfusion (two primary and one revision) experienced a complete resolution of their vertigo. In each case, the operated ear showed no response to the maximal caloric test postoperatively, confirming that vestibular function had been destroyed. This suggests that in order to relieve symptoms in patients with ipsilateral DEH, more conservative measures such as ELS surgery, cochleosacculotomy," and streptomycin perfusion can be chosen arbitrarily as either primary or subsequent procedures as an alternative to labyrinthectomy. Studies show that these more conservative procedures are equally effica-HUANG,L1N cious in terms of alleviating vertigo (even among elderly patients) and in preserving the inner ear structure."
Preserving the inner ear structure might become increasingly important, even in a deafened ear, now that cochlear implantation has become a standard procedure for patients with total or profound bilateral hearing loss. However, we do not recommend streptomycin perfusion for patients with contralateral or bilateral DEH, in whom hearing preservation is extremely important. In our experience, attempts to titrate streptomycin compound doses can be problematical because some of the compound is often regurgitated on administration. It is also very likely that titration is made difficult by differences in individual patients' inner ear pathology, which might reduce the effect of the trabecular meshwork and membrana limitans. Therefore, predicting the amount of streptomycin, the injection pressure, and the injection speed necessary to avoid damage to the cochlea is difficult.
In patients with contralateral DEH or Meniere's disease who still have significant hearing, preservation of hearing during surgery on the only-hearing or better-hearing ear is of the utmost importance. Therefore, only the safest techniques should be attempted. In 1978, Schuknecht wrote that there was no satisfactory therapy available for contralateral DEH.3 In 1983, Morrison reported on ELS surgery on the only-hearing or better-hearing ear in patients with contralateral DEH and concluded that because the risk of surgical anacusis was only 1% with ELS surgery, it should be the only option for these patients." In 1988, Hicks and Wright argued that only ELS surgery should be performed to alleviate disabling vertigo in contralateral DEH. 5 We agree. In our study, ELS cured vertigo in 13 of the 16 patients on whom it was performed (table 4). The other three patients continued to experience dizziness, which was controlled medically. Hearing was preserved in all but one patient. One patient experienced an improvement of 10 dB.
Among patients with intractable Meniere's disease, the success rate of ELS surgery has been reported to range from approximately 70 to 95% for relieving vertigo and approximately 60 to 90% for improving and sustaining hearing. 12-15,21,29 Meanwhile, the incidence of surgical anacusis is less than 2%. In this context, it is worth noting that the incidence of anacusis following ELS surgery is marginally higher when endolymph is drained from the duct than from the sac." Although there was no cochlear function damage observed in our series, it appears that endolymphatic duct procedures with intraductal capillary devices are best avoided-or at least performed cautiously-in patients with contralateral DEH in order to avoid adverse or catastrophic effects on inner ear function. It is interesting to note that promising results have been achieved with a drainage method (endolymphatic sac balloon surgery) devised by the primary author (T.S.H.).30 This technique involves opening the endolym-90 phatic sac and expanding its lumen by inserting a Silastic ribbon sheet that is fan-folded within the sac.
The chances of achieving long-term vertigo control are greater with vestibular nerve section than with ELS surgery.":" However, vestibular nerve section is difficult to perform and carries a higher risk of compromising inner ear function (>10% anacusis) and morbidity. (Even so, Silverstein et al reported that none of their cases suffered total hearing loss.") Therefore, ELS surgery remains the procedure of choice in the only-hearing or better-hearing ear in patients with contralateral DEH.
If symptoms recur, revision sac surgery can be as effective as primary ELS surgery. Paparella and Sajjadi" reported that revision sac surgery not only eliminated vertigo, it greatly improved hearing in some cases, a finding that paralleled our own." Paparella and Sajjadi also noted thatthe effectiveness of this revision procedure was similar to that of the primary operation.
A newer procedure was recently developed that involves the use of the Round Window micro-Cath (IntraEar Corp.; Cupertino, Calif.). This perfusion device is equipped with a micropump that provides a continuous delivery of minute, controllable amounts of gentamicin. Absorption is maximized by allowing the gentamicin to permeate through the round window membrane and into the inner ear. This technique provides adequate gentamicin toxicity to the vestibular receptor while sparing cochlear function. Our experience with this procedure in controlling vertigo while preserving hearing have been very positive. 
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